Bakris GL - Search Results

1

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.

2

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy.

Epstein M, Bakris G. Epstein M, et al. Arch Intern Med. 1996 Sep 23;156(17):1969-78. Arch Intern Med. 1996. PMID: 8823150 Review.

3

Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy.

Smith AC, Toto R, Bakris GL. Smith AC, et al. Among authors: bakris gl. Kidney Int. 1998 Sep;54(3):889-96. doi: 10.1046/j.1523-1755.1998.00055.x. Kidney Int. 1998. PMID: 9734613 Free article. Clinical Trial.

4

Hypertension in patients with diabetes. Why is aggressive treatment essential?

Bakris G, Sowers J, Epstein M, Williams M. Bakris G, et al. Postgrad Med. 2000 Feb;107(2):53-6, 61-4. doi: 10.3810/pgm.2000.02.884. Postgrad Med. 2000. PMID: 10689408 Review.

5

Hypertension in patients with diabetes. Strategies for drug therapy to reduce complications.

Sowers JR, Williams M, Epstein M, Bakris G. Sowers JR, et al. Postgrad Med. 2000 Apr;107(4):47-54, 60. doi: 10.3810/pgm.2000.04.990. Postgrad Med. 2000. PMID: 10778410 Review.

6

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Bakris GL, et al. Am J Kidney Dis. 2000 Sep;36(3):646-61. doi: 10.1053/ajkd.2000.16225. Am J Kidney Dis. 2000. PMID: 10977801 Review.

7

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D. Bakris GL, et al. Kidney Int. 2000 Nov;58(5):2084-92. doi: 10.1111/j.1523-1755.2000.00381.x. Kidney Int. 2000. PMID: 11044229 Free article. Clinical Trial.

8

Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.

Bakris GL, Smith AC, Richardson DJ, Hung E, Preston R, Goldberg R, Epstein M. Bakris GL, et al. J Hum Hypertens. 2002 Mar;16(3):185-91. doi: 10.1038/sj.jhh.1001315. J Hum Hypertens. 2002. PMID: 11896508 Clinical Trial.

9

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group. Wright JT Jr, et al. JAMA. 2002 Nov 20;288(19):2421-31. doi: 10.1001/jama.288.19.2421. JAMA. 2002. PMID: 12435255 Clinical Trial.

10

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R. Eknoyan G, et al. Among authors: bakris gl. Am J Kidney Dis. 2003 Oct;42(4):617-22. doi: 10.1016/s0272-6386(03)00826-6. Am J Kidney Dis. 2003. PMID: 14520612 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

837 results

Search Page